Latest filing published 09 Nov 2010 for ROCK CREEK PHARMACEUTICALS, INC..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Paul L. Perito: trading record in brief
Paul L. Perito appears in our data through filings on Rock Creek Pharmaceuticals, Inc. shares, published by SEC (Form 4). In total, 25 filings cover trades dated from 28 August 2007 to 5 November 2010.
Market trades split into 23 purchases (€63k) and 1 sale (€3.4M). The amount is not disclosed for 1 filing. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 1 option exercise. So far in 2010, the count stands at 1 purchase and no sales.
In size, the median ticket on the buying side is €877.
The newest entry dates from 9 November 2010: an open-market purchase, in Rock Creek Pharmaceuticals, Inc. The median gap between trade and publication is zero days: most filings appear on the same day. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Paul L. Perito
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 50,000 sharesCommon StockSEC:0001209191-10-054063:0Canonical exit: 3 Feb 2011 (T+90)
- 1,000 shares@ US$0.819Common StockSEC:0001209191-09-052816:0Canonical exit: 14 Feb 2010 (T+90)
- 998 shares@ US$0.8191Common StockSEC:0001209191-09-052816:1Canonical exit: 14 Feb 2010 (T+90)
- 402 shares@ US$0.8194Common StockSEC:0001209191-09-052816:2Canonical exit: 14 Feb 2010 (T+90)
- 17,600 shares@ US$0.82Common StockSEC:0001209191-09-052816:3Canonical exit: 14 Feb 2010 (T+90)
- 14,184 shares@ US$0.80Common StockSEC:0001209191-09-052592:0Canonical exit: 11 Feb 2010 (T+90)
- 1,816 shares@ US$0.7935Common StockSEC:0001209191-09-052592:1Canonical exit: 11 Feb 2010 (T+90)
- 2,100 shares@ US$0.7988Common StockSEC:0001209191-09-052592:2Canonical exit: 11 Feb 2010 (T+90)
- 2,200 shares@ US$0.7989Common StockSEC:0001209191-09-052592:3Canonical exit: 11 Feb 2010 (T+90)
- 700 shares@ US$0.799Common StockSEC:0001209191-09-052592:4Canonical exit: 11 Feb 2010 (T+90)
- 2,800 shares@ US$0.7998Common StockSEC:0001209191-09-052592:5Canonical exit: 11 Feb 2010 (T+90)
- 6,200 shares@ US$0.7999Common StockSEC:0001209191-09-052592:6Canonical exit: 11 Feb 2010 (T+90)
- 200 shares@ US$0.7799Common StockSEC:0001209191-09-052248:0Canonical exit: 10 Feb 2010 (T+90)
- 1,500 shares@ US$0.78Common StockSEC:0001209191-09-052248:1Canonical exit: 10 Feb 2010 (T+90)
- 600 shares@ US$0.7892Common StockSEC:0001209191-09-052248:2Canonical exit: 10 Feb 2010 (T+90)
- 33,071 shares@ US$0.79Common StockSEC:0001209191-09-052248:3Canonical exit: 10 Feb 2010 (T+90)
- 400 shares@ US$0.7899Common StockSEC:0001209191-09-052248:4Canonical exit: 10 Feb 2010 (T+90)
- 278 shares@ US$0.7997Common StockSEC:0001209191-09-052248:5Canonical exit: 10 Feb 2010 (T+90)
- 6,700 shares@ US$0.7998Common StockSEC:0001209191-09-052248:6Canonical exit: 10 Feb 2010 (T+90)
- 200 shares@ US$0.7996Common StockSEC:0001209191-09-052248:7Canonical exit: 10 Feb 2010 (T+90)
- 100 shares@ US$0.7999Common StockSEC:0001209191-09-052248:8Canonical exit: 10 Feb 2010 (T+90)
- 6,951 shares@ US$0.80Common StockSEC:0001209191-09-052248:9Canonical exit: 10 Feb 2010 (T+90)
- 1,000,000 shares@ US$1.69Common StockSEC:0001181431-09-020976:0
- 1,000,000 shares@ US$4.50Common StockSEC:0001181431-09-020976:1
- 12,500 shares@ US$1.01Common StockSEC:0001181431-07-054565:0Canonical exit: 26 Nov 2007 (T+90)
25 of 25 declarations